Security
JATT · JATT II Acquisition Corp.
JATTNASDAQCommon stockCurrentCIK 2112446Updated Sep 27, 2026
JATT price & chart
Loading TradingView…
NASDAQ:JATT on TradingView ↗About the company
We are a blank check company incorporated on January 13, 2026, as a Cayman Islands exempted company with limited liability for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any potential business combination target with respect to our initial business combination.
In the news
No coverage from other publishers is available.
Recent filings
SCHEDULE 13D/A filing
SCHEDULE 13D filing
10-Q filing
4 filing
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Regulation FD Disclosure
Items 1.01, 3.02, 7.01, 9.01
Show 5 more recent filings
10-Q filing
Other Events
Items 8.01, 9.01
4 filing
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Other Events
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
424B4 filing
Offerings
Registration 333-294294
- Gross proceeds
- 60000000.0
- Net proceeds
- 57600000.0
- Deal price
- 10.0
- Shares
- 6000000
- Offering amount
- $60,000,000
- Offering price
- market-price
- Ticker
- JATT
Filing attachments
d136998dex991.htm · 8-K · 2026-06-29
EX-99.1 8 d136998dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases Oversubscribed $225 million concurrent private investment in public equity (“PIPE”) with available cash to the combined company at closing anticipated to fund TALA-125 through a Phase 2b proof-of-concept study data rea…
Read attachment ↗d136998dex992.htm · 8-K · 2026-06-29
EX-99.2 9 d136998dex992.htm EX-99.2 EX-99.2 Exhibit 99.2 Corporate Presentation June 2026 Disclaimer and forward-looking statements This confidential presentation has been made available to you for informal purposes only with the consent of Talawar Tx Inc. (the “Company” or Talawar ) and JATT II Acquisition Corp (“JATT”) and has been prepared to assist interested parties in making their own evaluation wi th respect to a business combination between the Company and JATT and related transact…
Read attachment ↗ea028755501ex99-1.htm · 8-K · 2026-04-24
EX-99.1 2 ea028755501ex99-1.htm BALANCE SHEET DATED APRIL 20, 2026 Exhibit 99.1 JATT II ACQUISITION CORP INDEX TO FINANCIAL STATEMENT Page Financial Statement of JATT II Acquisition Corp: Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of April 20, 2026 F-3 Notes to Financial Statement F-4 F-1 REPORT OF INDEPENDENT REGISTERED …
Read attachment ↗ea028706601ex99-1.htm · 8-K · 2026-04-21
EX-99.1 9 ea028706601ex99-1.htm PRESS RELEASE, DATED APRIL 16, 2026 Exhibit 99.1 JATT II Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering Westfield, New Jersey, United States, April 16, 2026 (GLOBE NEWSWIRE) - JATT II Acquisition Corp (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the pricing of its initial public offering of 6,000,000 ordinary shares at an offering price of $10.00…
Read attachment ↗ea028706601ex99-2.htm · 8-K · 2026-04-21
EX-99.2 10 ea028706601ex99-2.htm PRESS RELEASE, DATED APRIL 20, 2026 Exhibit 99.2 JATT II Acquisition Corp Announces Closing of $60,000,000 Initial Public Offering Westfield, New Jersey, United States, April 20, 2026 (GLOBE NEWSWIRE) - JATT II Acquisition Corp (the “Company”) announced the closing of its initial public offering of 6,000,000 ordinary shares at an offering price of $10.00 per ordinary share on April 20, 2026. Total gross proceeds from the offering were $60,000,000 before de…
Read attachment ↗ea028469001ex4-1.htm · S-1/A · 2026-04-02
EX-4.1 6 ea028469001ex4-1.htm SPECIMEN ORDINARY SHARE CERTIFICATE Exhibit 4.1 SHARES NUMBER C- SEE REVERESE FPR CERTAIN DEFINITIONS CUSIP G50765 109 JATT II ACQUISITION CORP ORDINARY SHARES THIS CERTIFIES THAT is the owner of ordinary shares, par value $0.0001 per share (each, an “Ordinary Share”), of JATT II Acquisition Corp, a Cayman Islands exempted company (the “Company”), transferable on the books of the Company in person or by duly authorized attorney upon surrender of this certi…
Read attachment ↗